KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Accumulated Expenses (2017 - 2025)

Historic Accumulated Expenses for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $7.5 million.

  • Cardlytics' Accumulated Expenses fell 1058.74% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 1058.74%. This contributed to the annual value of $7.2 million for FY2024, which is 3847.54% down from last year.
  • According to the latest figures from Q3 2025, Cardlytics' Accumulated Expenses is $7.5 million, which was down 1058.74% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Accumulated Expenses ranged from a high of $22.0 million in Q1 2023 and a low of $6.8 million during Q2 2024
  • Over the past 5 years, Cardlytics' median Accumulated Expenses value was $10.5 million (recorded in 2023), while the average stood at $12.3 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 15877.08% in 2021, then tumbled by 6320.6% in 2024.
  • Over the past 5 years, Cardlytics' Accumulated Expenses (Quarter) stood at $19.6 million in 2021, then grew by 8.74% to $21.3 million in 2022, then plummeted by 45.34% to $11.7 million in 2023, then tumbled by 38.48% to $7.2 million in 2024, then grew by 4.17% to $7.5 million in 2025.
  • Its Accumulated Expenses was $7.5 million in Q3 2025, compared to $7.2 million in Q2 2025 and $8.4 million in Q1 2025.